Operating Lease, Right-of-Use Asset of Arcus Biosciences, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arcus Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Arcus Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $65,000,000, a 29% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Arcus Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $65,000,000 -$27,000,000 -29% 31 Dec 2024 10-K 25 Feb 2025 2024 FY
Q4 2023 $92,000,000 -$8,000,000 -8% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $100,000,000 -$5,000,000 -4.8% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q3 2022 $102,073,000 +$66,520,000 +187% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $104,025,000 +$67,888,000 +188% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $102,992,000 +$90,749,000 +741% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $105,000,000 +$92,219,000 +722% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $35,553,000 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $36,137,000 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $12,243,000 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $12,781,000 31 Dec 2020 10-K 23 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.